4.27
price up icon0.00%   0.00
 
loading

Exicure Inc (XCUR) 最新ニュース

pulisher
Feb 12, 2026

Market Pulse: Does Exicure Inc stock have upside surprise potentialJuly 2025 WrapUp & Smart Allocation Stock Reports - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 10, 2026

Exicure announces board and executive changes, CEO and CFO resignations By Investing.com - Investing.com India

Feb 10, 2026
pulisher
Feb 10, 2026

Exicure announces board and executive changes, CEO and CFO resignations - Investing.com

Feb 10, 2026
pulisher
Feb 10, 2026

Exicure Announces Major Leadership and Board Restructuring - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

Leadership shake-up at Exicure (NASDAQ: XCUR) as CEO, CFO and directors exit - Stock Titan

Feb 10, 2026
pulisher
Feb 09, 2026

Why Exicure Inc. stock remains on watchlistsJuly 2025 Trends & Technical Pattern Recognition Alerts - mfd.ru

Feb 09, 2026
pulisher
Feb 05, 2026

Aug Intraday: What is the Moat Score of Exicure IncTrade Risk Summary & Capital Protection Trading Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Exicure announces publication of results from Phase 2 study of burixafor - TipRanks

Feb 05, 2026
pulisher
Feb 05, 2026

Exicure (XCUR) Publishes Promising Phase 2 Study Results for Bur - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

Exicure (XCUR) Publishes Promising Phase 2 Study Results for Burixafor - GuruFocus

Feb 05, 2026
pulisher
Feb 05, 2026

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant - The Manila Times

Feb 05, 2026
pulisher
Feb 05, 2026

Exicure, Inc. Publishes Phase 2 Study Results for Burixafor, a Novel CXCR4 Inhibitor in Hematologic Disease Treatment - Quiver Quantitative

Feb 05, 2026
pulisher
Feb 05, 2026

Same-day stem cell collection seen in Exicure Phase 2 cancer trial - Stock Titan

Feb 05, 2026
pulisher
Feb 01, 2026

Market Catalysts: Can Exicure Inc expand into new marketsJuly 2025 Chart Watch & High Conviction Buy Zone Picks - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 29, 2026

Quarterly Earnings: Should I invest in NEPH before earningsWeekly Market Outlook & Daily Profit Maximizing Tips - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Jobs Data: Does Exicure Inc offer margin of safetyGap Up & Verified Entry Point Detection - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 28, 2026

Trade Report: What is the Moat Score of Exicure Inc2025 Sector Review & Trade Opportunity Analysis - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 24, 2026

Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up - TipRanks

Jan 24, 2026
pulisher
Jan 23, 2026

Market Trends: What is the Moat Score of Exicure IncJuly 2025 Update & Long-Term Safe Investment Ideas - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Exicure completes Phase 2 trial milestone and plans $1 million payment to GPCR Therapeutics - Investing.com UK

Jan 23, 2026
pulisher
Jan 22, 2026

Exicure to Pay GPCR Therapeutics $1 Million for First Milestone Completion - 아시아경제

Jan 22, 2026
pulisher
Jan 22, 2026

Exicure Achieves Milestone in Burixafor Phase 2 Program - TipRanks

Jan 22, 2026
pulisher
Jan 22, 2026

Exicure Achieves First Milestone in Collaboration with GPCR Therapeutics - TradingView

Jan 22, 2026
pulisher
Jan 22, 2026

Exicure to present phase 2 burixafor data at 2026 transplantation meeting - Investing.com Nigeria

Jan 22, 2026
pulisher
Jan 21, 2026

Major Exicure Stakeholder Makes Bold Move With Large Share Sale - TipRanks

Jan 21, 2026
pulisher
Jan 21, 2026

Insider Sell: Hitron Exicure Sells 258,367 Shares of Exicure Inc (XCUR) - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure HiTron sells shares worth $1.16 million By Investing.com - Investing.com Nigeria

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure HiTron sells shares worth $1.16 million - Investing.com

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings - TipRanks

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure (XCUR) to Showcase Phase 2 Trial Data on Burixafor at 20 - GuruFocus

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure, Inc. to Present Phase 2 Trial Results for Burixafor at 2026 ASTCT and CIBMTR Tandem Meetings - Quiver Quantitative

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings - The Manila Times

Jan 21, 2026
pulisher
Jan 21, 2026

Exicure to Present Data From Burixafor Phase 2 Trial at the 2026 Tandem Meetings - 富途牛牛

Jan 21, 2026
pulisher
Jan 20, 2026

Major Exicure Stakeholder Makes a Big Move With a Multi-Million Dollar Stock Sale - TipRanks

Jan 20, 2026
pulisher
Jan 20, 2026

Exicure HiTron Inc sells $3.3m in Exicure (XCUR) stock By Investing.com - Investing.com Nigeria

Jan 20, 2026
pulisher
Jan 20, 2026

Signal Recap: Whats the outlook for Exicure Incs sectorWeekly Trade Report & AI Based Buy and Sell Signals - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Insider Sell Alert: Hitron Exicure Sells 734,747 Shares of Exicu - GuruFocus

Jan 20, 2026
pulisher
Jan 20, 2026

Exicure HiTron Inc sells $3.3m in Exicure (XCUR) stock - Investing.com

Jan 20, 2026
pulisher
Jan 17, 2026

Understanding Momentum Shifts in (XCUR) - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 17, 2026

Exicure (NASDAQ:XCUR) Stock Rating Upgraded by Wall Street Zen - Defense World

Jan 17, 2026
pulisher
Jan 15, 2026

Exicure, Inc. (NASDAQ:XCUR) Short Interest Down 42.7% in December - Defense World

Jan 15, 2026
pulisher
Jan 15, 2026

Exicure (NASDAQ:XCUR) Shares Up 1.2% – Time to Buy? - Defense World

Jan 15, 2026
pulisher
Jan 09, 2026

Insider Sale: 10% owner at $XCUR Sells 741,272 Shares | XCUR Stock News - Quiver Quantitative

Jan 09, 2026
pulisher
Jan 09, 2026

Why Exicure Inc. (2H0) stock attracts HNW investorsJuly 2025 Rallies & Stepwise Entry and Exit Trade Signals - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Exicure presents topline data from burixafor combination trial - MSN

Jan 08, 2026
pulisher
Jan 08, 2026

Exicure HiTron sells $3.3m in Exicure shares By Investing.com - Investing.com South Africa

Jan 08, 2026
pulisher
Jan 08, 2026

Exicure Hitron Sells Over 740K Shares - TradingView — Track All Markets

Jan 08, 2026
pulisher
Jan 08, 2026

Exicure HiTron sells $3.3m in Exicure shares - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Why Exicure Inc. stock is rated strong buyMarket Growth Review & Daily Stock Trend Watchlist - ulpravda.ru

Jan 08, 2026
$26.71
price down icon 0.04%
$45.51
price up icon 1.57%
$102.25
price up icon 1.57%
$107.50
price up icon 1.71%
$151.32
price up icon 3.48%
biotechnology ONC
$350.38
price up icon 1.00%
大文字化:     |  ボリューム (24 時間):